
GlaxoSmithKline plc GSK
$ 51.68
0.58%
Quarterly report 2025-Q4
added 05-06-2026
GlaxoSmithKline plc PEG Ratio 2011-2026 | GSK
Annual PEG Ratio GlaxoSmithKline plc
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5.78 | -4.93 | 15.7 | 1.11 | -5.48 | 0.637 | 1.43 | 5.68 | -15 | -0.85 | 0.0423 | -0.571 | 0.799 | -1.6 | 0.0696 |
All numbers in GBP currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 15.7 | -15 | 0.188 |
PEG Ratio of other stocks in the Biotechnology industry
| Issuer | PEG Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
FSD Pharma
HUGE
|
0.0115 | - | 5743.5 % | $ 69.7 M | ||
|
MorphoSys AG
MOR
|
-0.169 | - | 2.43 % | $ 254 M | ||
|
Happiness Biotech Group Limited
HAPP
|
-0.156 | - | 1.35 % | $ 17.8 M | ||
|
Arcturus Therapeutics Holdings
ARCT
|
0.0261 | $ 7.14 | 1.56 % | $ 196 M | ||
|
AgeX Therapeutics
AGE
|
0.000009 | - | -10.17 % | $ 12.2 K | ||
|
I-Mab
IMAB
|
-0.75 | - | - | $ 866 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
-0.747 | - | - | $ 40.3 B | ||
|
Genfit SA
GNFT
|
-0.0281 | - | 2.54 % | $ 160 B | ||
|
BioNTech SE
BNTX
|
0.00586 | $ 93.13 | 1.07 % | $ 22.5 B | ||
|
AstraZeneca PLC
AZN
|
0.103 | - | - | $ 96.9 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
0.254 | - | -1.52 % | $ 24.7 M | ||
|
Athira Pharma
ATHA
|
0.0276 | - | - | $ 269 M | ||
|
BiondVax Pharmaceuticals Ltd.
BVXV
|
1.57 | - | 0.74 % | $ 768 M | ||
|
Compugen Ltd.
CGEN
|
-0.077 | $ 2.71 | -3.16 % | $ 253 M | ||
|
Galera Therapeutics
GRTX
|
0.0195 | - | -32.59 % | $ 7.61 M | ||
|
Midatech Pharma plc
MTP
|
-0.73 | - | -18.52 % | $ 27.3 M | ||
|
Affimed N.V.
AFMD
|
3.06 | - | -34.95 % | $ 21.5 M | ||
|
Институт стволовых клеток человека
ISKJ
|
-2.8 | - | - | - | ||
|
Checkmate Pharmaceuticals
CMPI
|
0.189 | - | - | $ 231 M | ||
|
Celyad Oncology SA
CYAD
|
0.0181 | - | - | $ 12.5 M | ||
|
Berkeley Lights
BLI
|
0.863 | - | -7.31 % | $ 87 M | ||
|
Generation Bio Co.
GBIO
|
-0.476 | - | - | $ 344 M | ||
|
IMV
IMV
|
-0.283 | - | - | $ 13.1 M | ||
|
Akero Therapeutics
AKRO
|
-1.49 | - | - | $ 3.67 B | ||
|
Akouos
AKUS
|
0.105 | - | 0.23 % | $ 488 M | ||
|
Ayala Pharmaceuticals
AYLA
|
0.0783 | - | - | $ 7.46 M | ||
|
Freeline Therapeutics Holdings plc
FRLN
|
-0.0155 | - | - | $ 384 M | ||
|
Gracell Biotechnologies
GRCL
|
-0.448 | - | - | $ 3.37 B | ||
|
Coherus BioSciences
CHRS
|
-0.0207 | $ 1.68 | 4.04 % | $ 197 M | ||
|
Anika Therapeutics
ANIK
|
0.147 | $ 14.64 | -1.61 % | $ 210 M | ||
|
Advaxis
ADXS
|
-0.00008 | - | -9.65 % | $ 45.9 M | ||
|
Aeterna Zentaris
AEZS
|
0.00152 | - | 5.93 % | $ 314 M | ||
|
Aeglea BioTherapeutics
AGLE
|
-0.0134 | - | - | $ 1.01 B | ||
|
CureVac N.V.
CVAC
|
4.05 | - | - | $ 867 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
-0.0406 | - | - | $ 26.5 M | ||
|
AIkido Pharma
AIKI
|
-0.000778 | - | 1.93 % | $ 17.4 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
-0.000013 | $ 3.46 | 1.74 % | $ 5.7 M | ||
|
Aptose Biosciences
APTO
|
-0.000164 | - | -45.71 % | $ 1.2 M | ||
|
Aptinyx
APTX
|
0.00516 | - | -39.0 % | $ 4.57 M | ||
|
Albireo Pharma
ALBO
|
-5.17 | - | -0.23 % | $ 916 M | ||
|
AlloVir
ALVR
|
0.1 | - | 4.14 % | $ 49.1 M | ||
|
Allakos
ALLK
|
-0.0646 | - | - | $ 28.6 M | ||
|
Arcutis Biotherapeutics
ARQT
|
6.77 | $ 21.02 | 0.77 % | $ 2.67 B | ||
|
Allena Pharmaceuticals
ALNA
|
0.0566 | - | 3.16 % | $ 1.9 M | ||
|
Ampio Pharmaceuticals
AMPE
|
-0.000175 | - | -11.43 % | $ 502 K | ||
|
Applied Molecular Transport
AMTI
|
0.133 | - | - | $ 10.1 M | ||
|
Alpine Immune Sciences
ALPN
|
4.18 | - | - | $ 2.17 B |